Optimizing the value of lenalidomide maintenance by extended genetic profiling: an analysis of 556 patients in the Myeloma XI trial.
Panopoulou A, Cairns DA, Holroyd A, Nichols I, Cray N, Pawlyn C, Cook G, Drayson M, Boyd K, Davies FE, Jenner M, Morgan GJ, Owen R, Houlston R, Jackson G, Kaiser MF.
Panopoulou A, et al. Among authors: cray n.
Blood. 2023 Apr 6;141(14):1666-1674. doi: 10.1182/blood.2022018339.
Blood. 2023.
PMID: 36564045
Free PMC article.
Clinical Trial.